Abbruzzese JL - Search Results

1

Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin.

Abbruzzese JL, Abbruzzese MC, Lenzi R, Hess KR, Raber MN. Abbruzzese JL, et al. Among authors: abbruzzese mc. J Clin Oncol. 1995 Aug;13(8):2094-103. doi: 10.1200/JCO.1995.13.8.2094. J Clin Oncol. 1995. PMID: 7636553

2

Phase II evaluation of iproplatin in patients with advanced gastric and pancreatic cancer.

Hubbard KP, Pazdur R, Ajani JA, Braud E, Blaustein A, King M, Llenado-Lee M, Winn R, Levin B, Abbruzzese JL. Hubbard KP, et al. Among authors: abbruzzese jl. Am J Clin Oncol. 1992 Dec;15(6):524-7. Am J Clin Oncol. 1992. PMID: 1449117 Clinical Trial.

3

Unknown primary tumors.

Raber MN, Abbruzzese JL, Frost P. Raber MN, et al. Among authors: abbruzzese jl. Curr Opin Oncol. 1992 Feb;4(1):3-9. Curr Opin Oncol. 1992. PMID: 1591292 No abstract available.

4

Continuous infusion 5-fluorouracil, etoposide and cis-diamminedichloroplatinum in patients with metastatic carcinoma of unknown primary origin.

Raber MN, Faintuch J, Abbruzzese JL, Sumrall C, Frost P. Raber MN, et al. Among authors: abbruzzese jl. Ann Oncol. 1991 Jul;2(7):519-20. doi: 10.1093/oxfordjournals.annonc.a058007. Ann Oncol. 1991. PMID: 1911461 Free article. Clinical Trial.

5

Metastatic adenocarcinoma to the neck from an unknown primary source.

Lee NK, Byers RM, Abbruzzese JL, Wolf P. Lee NK, et al. Among authors: abbruzzese jl. Am J Surg. 1991 Oct;162(4):306-9. doi: 10.1016/0002-9610(91)90137-3. Am J Surg. 1991. PMID: 1951879

6

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine.

Abbruzzese JL, Grunewald R, Weeks EA, Gravel D, Adams T, Nowak B, Mineishi S, Tarassoff P, Satterlee W, Raber MN, et al. Abbruzzese JL, et al. J Clin Oncol. 1991 Mar;9(3):491-8. doi: 10.1200/JCO.1991.9.3.491. J Clin Oncol. 1991. PMID: 1999720 Clinical Trial.

7

Phase I clinical trial of cisplatin given i.v. with 5-fluorouracil and high-dose folinic acid.

Abbruzzese JL, Amato R, Schmidt S, Raber MN, Frost P. Abbruzzese JL, et al. Cancer Chemother Pharmacol. 1990;26(3):159-62. doi: 10.1007/BF02897192. Cancer Chemother Pharmacol. 1990. PMID: 2357761

8

Evaluation of pre- and postoperative chemotherapy for resectable adenocarcinoma of the esophagus or gastroesophageal junction.

Ajani JA, Roth JA, Ryan B, McMurtrey M, Rich TA, Jackson DE, Abbruzzese JL, Levin B, DeCaro L, Mountain C. Ajani JA, et al. Among authors: abbruzzese jl. J Clin Oncol. 1990 Jul;8(7):1231-8. doi: 10.1200/JCO.1990.8.7.1231. J Clin Oncol. 1990. PMID: 2358838

9

Phase I trial of semustine plus weekly fluorouracil and high-dose leucovorin calcium in patients with advanced colorectal cancer.

Abbruzzese JL, Weeks A, Raber MN, Gravel D, DuBrow RA, Levin B, Grem J, Chun HG. Abbruzzese JL, et al. J Natl Cancer Inst. 1989 Dec 6;81(23):1840-2. doi: 10.1093/jnci/81.23.1840. J Natl Cancer Inst. 1989. PMID: 2585532 No abstract available.

10

Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU) terminated by severe neurologic toxicity.

Abbruzzese JL, Schmidt S, Raber MN, Levy JK, Castellanos AM, Legha SS, Krakoff IH. Abbruzzese JL, et al. Invest New Drugs. 1989 Jul;7(2-3):195-201. doi: 10.1007/BF00170857. Invest New Drugs. 1989. PMID: 2793372

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

501 results

Search Page

Filters